Lexogen Overview
- Year Founded
-
2007
- Status
-
Private
- Employees
-
60
- Latest Deal Type
-
2ndary - Private
- Investors
-
1
Lexogen General Information
Description
Developer of profiling technologies designed to offer a detailed analysis of the complete transcriptome and individual full-length RNAs of interest. The company's technology specializes in developing RNA-Seq library preparation kits, RNA analysis, and RNA-Seq data analysis software, enabling clients and scientists to perform various research and development processes.
Contact Information
Website
www.lexogen.comCorporate Office
- Campus Vienna Biocenter 5
- Vienna, 1030
- Austria
Corporate Office
- Campus Vienna Biocenter 5
- Vienna, 1030
- Austria
Lexogen Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Secondary Transaction - Private | 01-Jun-2026 | Completed | Generating Revenue | |||
| 4. Later Stage VC | Completed | Generating Revenue | ||||
| 3. Seed Round | 01-Oct-2011 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 01-Aug-2007 | Completed | Startup | |||
| 1. Seed Round | 01-Jan-2007 | Completed | Startup |
Lexogen Patents
Lexogen Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2021354916-A1 | Method and means for generating transcribed nucleic acids | Pending | 02-Oct-2020 | ||
| CA-3193967-A1 | Method and means for generating transcribed nucleic acids | Pending | 02-Oct-2020 | ||
| EP-3978626-A1 | Method and means for generating transcribed nucleic acids | Inactive | 02-Oct-2020 | ||
| EP-4222284-A1 | Method and means for generating transcribed nucleic acids | Pending | 02-Oct-2020 | ||
| US-20230348963-A1 | Method and means for generating transcribed nucleic acids | Pending | 02-Oct-2020 | C12Q1/6869 |
Lexogen Signals
Lexogen Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Avv Investment | Venture Capital | Minority |
Lexogen FAQs
-
When was Lexogen founded?
Lexogen was founded in 2007.
-
Where is Lexogen headquartered?
Lexogen is headquartered in Vienna, Austria.
-
What is the size of Lexogen?
Lexogen has 60 total employees.
-
What industry is Lexogen in?
Lexogen’s primary industry is Biotechnology.
-
Is Lexogen a private or public company?
Lexogen is a Private company.
-
What is Lexogen’s current revenue?
The current revenue for Lexogen is .
-
Who are Lexogen’s investors?
Avv Investment has invested in Lexogen.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process